Postmenopausal hormone replacement therapy (HRT) may reduce progression of age-related maculopathy (ARM), according to the results of a cross-sectional study reported in the December issue of the American Journal of Ophthalmology.
‘Decisions regarding postmenopausal hormone therapies are becoming increasingly complex, and it is important to evaluate their effects, including testing their relationship to eye diseases of aging,’ lead author Johanna M. Seddon, MD, ScM, from the Massachusetts Eye and Ear Infirmary in Boston, Massachusetts, says in a news release.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!